A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens
- PMID: 8350057
- PMCID: PMC2191159
- DOI: 10.1084/jem.178.3.835
A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens
Abstract
A first or dominant immunization with one antigen markedly inhibited specific cytolytic T lymphocyte (CTL) responses to a second unrelated alloantigen without suppressing antibody responses to other antigens. Suppression was induced rapidly, became systemic, and could be transferred passively with only serum. Suppression did not result from elimination of cells capable of responding to the second antigen. The mechanisms responsible for this "priority of the first response" may be the same that help protect the fetus during pregnancy, promote renal allograft survival after multiple blood transfusions, and prevent effective CTL-mediated immunity to variants of tumor cells or infectious agents that arise during tumor progression or chronic infections.
Similar articles
-
A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens.J Exp Med. 1993 Sep 1;178(3):841-52. doi: 10.1084/jem.178.3.841. J Exp Med. 1993. PMID: 8350058 Free PMC article.
-
Suppressor T cells, distinct from "veto cells," are induced by alloantigen priming and mediate transferable suppression of cytotoxic T lymphocyte responses in vivo.J Immunol. 1985 Nov;135(5):2984-9. J Immunol. 1985. PMID: 2413108
-
Blood-transfusion-induced suppression of cytotoxic T lymphocyte responses in mice.Transplantation. 1983 Nov;36(5):520-5. doi: 10.1097/00007890-198311000-00010. Transplantation. 1983. PMID: 6227113
-
Alloantigen pretreatment induces a down-regulation of the in vivo subsequent development of cytotoxic T lymphocytes directed against linked alloantigens.Eur J Immunol. 1989 Aug;19(8):1365-71. doi: 10.1002/eji.1830190803. Eur J Immunol. 1989. PMID: 2789138
-
Protection against metastasis by immunization with an allogeneic lymphocyte antigen.Cancer Immunol Immunother. 1995 Dec;41(6):384-8. doi: 10.1007/BF01526558. Cancer Immunol Immunother. 1995. PMID: 8635196 Free PMC article.
Cited by
-
A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens.J Exp Med. 1993 Sep 1;178(3):841-52. doi: 10.1084/jem.178.3.841. J Exp Med. 1993. PMID: 8350058 Free PMC article.
-
Autoantibodies produced spontaneously by young 1pr mice carry transforming growth factor beta and suppress cytotoxic T lymphocyte responses.J Exp Med. 1995 May 1;181(5):1875-80. doi: 10.1084/jem.181.5.1875. J Exp Med. 1995. PMID: 7722461 Free PMC article.
-
T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.J Exp Med. 1996 Apr 1;183(4):1669-79. doi: 10.1084/jem.183.4.1669. J Exp Med. 1996. PMID: 8666925 Free PMC article.
-
Circulating immunoglobulin-bound transforming growth factor beta at a late tumour-bearing stage impairs antigen-specific responses of CD4+ T cells.Clin Exp Immunol. 2002 May;128(2):204-12. doi: 10.1046/j.1365-2249.2002.01806.x. Clin Exp Immunol. 2002. PMID: 12041507 Free PMC article.
-
Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells.Clin Cancer Res. 2020 Feb 1;26(3):679-689. doi: 10.1158/1078-0432.CCR-19-2209. Epub 2019 Oct 23. Clin Cancer Res. 2020. PMID: 31645352 Free PMC article.